Extracorporeal Membrane Oxygenation Machine Market Analysis

ECMO Machine Industry Insights

Component Analysis

• The oxygenators category held the largest revenue share, of ~40%, in 2024 in the market, and it is further projected to have the highest CAGR over the forecast period.
• This is due to the rising incidence of severe lung diseases among children and the growing awareness regarding the applications of ECMO devices.
• Moreover, these oxygenators are majorly used by perfusionists in cardiac surgical procedures in conjunction with heart-lung machines and are also extensively used in neonatal intensive care units associated with ECMO machines.
• The heat-cooler unit category is expected to witness significant growth during the forecast period.
• This can be ascribed to the wide use of these units in cardiothoracic or transplantation surgeries and the increase in incidences of cardiopulmonary diseases such as chronic obstructive pulmonary diseases and cystic fibrosis.

The components analyzed here are:

• Pumps
• Oxygenators (Largest and Fastest-Growing Category)
• Heater-Cooler Units
• Tubes
• Others

Patient Type Analysis

• In the ECMO market, the adult category generates the highest revenue, predominantly because of the rising geriatric population and increasing prevalence of critical illnesses in it.
• Life-threatening respiratory and cardiac conditions, such as cardiogenic shock, ARDS, cardiac arrest, and traumatic lung injuries, make adults a common recipient of ECMO therapy.
• Moreover, adults undergo a high number of heart and lung surgeries during which ECMO is needed.
• The neonates category is the fastest growing, with a CAGR of 8.0%, during this decade.
• As per the Centers for Disease Control and Prevention (CDC), nearly 1%—or 40,000 babies—are born with a congenital heart defect (CHD) in the U.S. each year. In total, 1 out of 4 babies suffers from a heart defect.
• The increasing rate of heart disorders, pneumonia, respiratory distress syndrome, CDH, and other serious illnesses among neonates makes ECMO support imperative.
• This has resulted in an expansion of dedicated programs and resources and the creation of special devices for this population.

The patient types analyzed here are:

• Neonates (Fastest-Growing Category)
• Pediatrics
• Adults (Largest Category)

Modality Analysis

Veno-arterial is the largest category in the extracorporeal membrane oxygenation machine market, with ~50% revenue, and it is the fastest-growing category too.

This can be attributed to its effectiveness and reliability in the exchange of gases, widespread use in cardiac arrest patients, and assistance with algorithmic life support techniques to reestablish blood flow.

Additionally, it is widely used to treat patients with thromboembolism and pulmonary hypertension, particularly in cases of abrupt decompensation, which leads to the extracorporeal membrane oxygenation machine market expansion.

The modalities analyzed here are:

• Veno-Arterial (Largest and Fastest-Growing Category)
• Veno-Venous
• Arterio-Venous

Application Analysis

ECMO machines used for respiratory applications accounted for the largest revenue share in 2024.

The rise in prevalence of target diseases increased smoking and tobacco use, and excessive alcohol consumption, which can lead to chronic diseases or respiratory failure, and the high need for early diagnosis and diagnostic imaging are the key factors responsible for the increasing market share of this category.

Extracorporeal cardiopulmonary resuscitation (ECPR) is the fastest-growing category, with a CAGR of 9.34%. This is owing to the increasing acknowledgment of the role of ECPR in treating cardiac arrest. The American Heart Association (AHA) and the Extracorporeal Life Support Organization (ELSO) suggest ECPR as it increases the rate of survival and neurological recovery compared to traditional CPR.

The applications analyzed here are:

• Respiratory (Largest and Fastest-Growing Category)
• Cardiac
• ECPR (Fastest-Growing Category)